Financial reports
ARS
2023 FY
Annual report to shareholders
1 Apr 24
10-K
2023 FY
Annual report
22 Feb 24
10-Q
2023 Q3
Quarterly report
31 Oct 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
2 May 23
ARS
2022 FY
Annual report to shareholders
11 Apr 23
10-K
2022 FY
Annual report
22 Feb 23
10-Q
2022 Q3
Quarterly report
1 Nov 22
10-Q
2022 Q2
Quarterly report
2 Aug 22
10-Q
2022 Q1
Quarterly report
27 Apr 22
Current reports
8-K
Repligen Appoints Maggie A. Pax to Board of Directors
19 Mar 24
8-K
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
21 Feb 24
8-K
Entry into a Material Definitive Agreement
15 Dec 23
8-K
Unregistered Sales of Equity Securities
7 Dec 23
8-K
Repligen Reports Third Quarter 2023 Financial Results
31 Oct 23
8-K
Repligen Appoints Olivier Loeillot As President and Chief Commercial Officer
2 Oct 23
8-K
Repligen Announces Agreement to Acquire
26 Sep 23
8-K
Repligen Appoints Jason K. Garland As Chief Financial Officer
12 Sep 23
8-K
Repligen Reports Second Quarter 2023 Financial Results
2 Aug 23
8-K
Amendments to Articles of Incorporation or Bylaws
22 May 23
Registration and prospectus
424B7
Prospectus with selling stockholder info
5 Nov 21
424B5
Prospectus supplement for primary offering
8 Dec 20
424B5
Prospectus supplement for primary offering
7 Dec 20
424B5
Prospectus supplement for primary offering
17 Jul 19
424B5
Prospectus supplement for primary offering
17 Jul 19
FWP
Free writing prospectus
17 Jul 19
424B5
Prospectus supplement for primary offering
15 Jul 19
424B5
Prospectus supplement for primary offering
15 Jul 19
D
$48M in equity, sold $48M, 1 investor
13 Jun 19
424B5
Prospectus supplement for primary offering
1 May 19
Proxies
DEFA14A
Additional proxy soliciting materials
1 Apr 24
DEF 14A
Definitive proxy
1 Apr 24
DEF 14A
Definitive proxy
11 Apr 23
PRE 14A
Preliminary proxy
24 Mar 23
DEFA14A
Additional proxy soliciting materials
11 Apr 22
DEF 14A
Definitive proxy
11 Apr 22
DEFR14A
Revised proxy
5 May 21
DEF 14A
Definitive proxy
21 Apr 21
DEF 14A
Definitive proxy
28 Apr 20
DEF 14A
Definitive proxy
18 Apr 19
Other
CT ORDER
Confidential treatment order
31 Jan 22
CT ORDER
Confidential treatment order
5 Jun 18
UPLOAD
Letter from SEC
8 Mar 17
CORRESP
Correspondence with SEC
14 Feb 17
CORRESP
Correspondence with SEC
24 Jan 17
CORRESP
Correspondence with SEC
9 Jan 17
UPLOAD
Letter from SEC
22 Dec 16
CT ORDER
Confidential treatment order
26 Jul 16
UPLOAD
Letter from SEC
25 Feb 15
CORRESP
Correspondence with SEC
19 Feb 15
Ownership